ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares
BIB
Get informed when a big investor buys or sells
+ FollowMarket Cap$43.7B
Close$
Share Statistics
| Market cap | $43.70 Billion |
|---|---|
| Enterprise Value | $43.52 Billion |
| Dividend Yield | $0.49 (0.40%) |
| Earnings per Share | $- |
| Beta | 1.2 |
| Outstanding Shares | - |
Return
| Return on Equity | -25.93% |
|---|---|
| Return on Assets | -23.92% |
| Return on Invested Capital | -27.36% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3333 |
| Enterprise Value to EBIT | -579.03 |
| Enterprise Value to Net Income | -618 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1786▲ 17.86% |
|---|---|
| Total Calls | 14,000▲ 57.30% |
| Total Puts | 2,500▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.22%▲ 2.05% |
|---|---|
| Total Invested | $3.60M▲ 69.79% |
| Investors Holding | 26▲ 5.00% |
ESG Score
No data
About ProShares - GENIUS Money Market ETF
62 employees
CEO: Patrick Chalhoub This particular fund is offered as a component within the ProShares Trust framework. Its central objective is to generate steady income, while concurrently prioritizing accessible funds and the safeguarding of investors' principal. A key...